about
In vivo imaging reveals a pioneer wave of monocyte recruitment into mouse skin woundsCX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration.Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosisImmune surveillance of the lung by migrating tissue monocytescGMP-AMP synthase paves the way to autoimmunityControl of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice.ADA2 deficiency: case report of a new phenotype and novel mutation in two sistersMutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overviewAssessment of Type I Interferon Signaling in Pediatric Inflammatory Disease.Reduced Il17a expression distinguishes a Ly6c(lo)MHCII(hi) macrophage population promoting wound healing.Human disease phenotypes associated with mutations in TREX1.Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.Tracking mouse bone marrow monocytes in vivo.Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population.Detection of interferon alpha protein reveals differential levels and cellular sources in disease.Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.Wound-associated macrophages control collagen 1α2 transcription during the early stages of skin wound healing.Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathway.Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells.TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.Type I interferon-mediated autoinflammation due to DNase II deficiency.No association of MDM2 SNP309 with risk of glioblastoma and prognosis.Polymorphisms in IFIH1: the good and the bad.Functional Definition of Progenitors Versus Mature Endothelial Cells Reveals Key SoxF-Dependent Differentiation Process.Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.An engineered CX3CR1 antagonist endowed with anti-inflammatory activity.UVB-induced melanocyte proliferation in neonatal mice driven by CCR2-independent recruitment of Ly6c(low)MHCII(hi) macrophages.Lack of Evidence From a Transgenic Mouse Model that the Activation and Migration of Melanocytes to the Epidermis after Neonatal UVR Enhances Melanoma Development.Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.Erratum: Corrigendum: Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cystsJAK inhibition in STING-associated interferonopathyJAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisAutosomal-dominant early-onset spastic paraparesis with brain calcification due to IFIH1 gain-of-functionST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosisDifferential Effects of Ultraviolet Irradiation in Neonatal versus Adult Mice Are Not Explained by Defective Macrophage or Neutrophil Infiltration
P50
Q27345333-F05471B1-D422-4D5A-BA29-BE2C562181EAQ33301145-D1DC05FA-874B-41C4-BDBE-9EA9E7F1A396Q33398937-076A1FAF-2487-4920-BF02-2476C458FFAAQ35879555-210804F2-85BB-4144-802C-1B489D9A5310Q35906930-3BED91B1-1DB8-4CB3-BF6F-17D8B83A1690Q36207307-02B1126D-5D86-4C27-A80E-0E97F4FBB22CQ36879234-128D1294-ABC4-476B-8598-6298068CBE40Q36933267-0759EB5D-D71D-4294-BEF6-4C2A34809153Q37302596-5DBEE85B-FA32-4D74-8608-FF22E85BFC72Q37415269-EFD15560-D0C4-47D0-A9E6-F8653ABC4440Q37666293-854E48C3-F7C9-4DAA-917A-2231A84DB5F9Q38319317-8F1B3CF5-0F1A-4188-BEE4-791CCE6FB9BDQ38366756-573EF69B-9AD7-4233-B5B3-DBA1221DADCBQ38381558-52348354-E4E1-4852-8305-A4214391AFCFQ39021414-A7BFF4B9-2FDF-4C18-9935-24C3AA4BA1E7Q39737812-EEC98971-BC74-4088-B1A4-787D263C15BAQ40062598-C10A5A28-AA0D-4ADC-B4E0-F6F712395099Q40237578-F2811DEB-D57A-4CF4-8070-78C54E21D214Q40243822-358CD7E2-6737-4DC5-AF31-C5163389979AQ44302400-37CAA12C-5183-4492-B414-0BBED7326873Q45370711-6C01CAE9-42DC-4523-81BC-8ED6CB62D59DQ46571310-DAE99489-713C-4E96-B278-0582390E856AQ46955068-3F1FC7FA-D29F-49B9-B5B6-FAC3A5C8CD4AQ47108722-651FF937-7605-4B94-B9F1-F0254C74FCF6Q48136292-E42E7A26-3590-45CC-9982-4A90DE3C4B60Q48250439-F858A467-302B-4A1E-A9BA-4CBFF50DBB32Q48920287-D8C06921-23AB-47E1-98E2-6E9C9EA6607AQ49897563-CF79D304-0360-4F6A-BA26-8B2B9B58FF8FQ51167771-3C469B0F-3432-4567-8C9B-0F89CF15E6C7Q51778397-0FD1AB93-8008-44AC-AF79-38138753E368Q51837893-529AB661-11E1-40FA-9D73-A12C743672F9Q53482885-16010D02-0B77-4F5F-8E61-7889371AF4DDQ54177981-E9E6C591-C65C-43EA-A8E1-DEC07C9CBCF0Q55465615-F2B07BF6-E227-4C34-9D98-604709542A3CQ56923019-951B3F70-08B0-4CD4-A1B1-331396C001B6Q56923068-E4E56190-80EC-4B62-BBBE-AA7352582251Q56965247-59D437B5-68FB-4070-AC4C-8F934D0A3C62Q57204229-42AE8AB1-D9EC-44F1-8EC7-4AF424E94A47Q57913857-EC4EAE6F-00E2-44BD-B88C-3B33A40EDC31Q57913868-18FEBD72-3D85-44D1-9EA5-1EEA4EF6B49C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mathieu Rodero
@ast
Mathieu Rodero
@en
Mathieu Rodero
@es
Mathieu Rodero
@sl
type
label
Mathieu Rodero
@ast
Mathieu Rodero
@en
Mathieu Rodero
@es
Mathieu Rodero
@sl
prefLabel
Mathieu Rodero
@ast
Mathieu Rodero
@en
Mathieu Rodero
@es
Mathieu Rodero
@sl
P1053
C-8083-2011
P106
P1153
23009897100
P21
P31
P3829
P496
0000-0002-1300-0187